SummitTX Capital’s Savara SVRA Stock Holding History

SummitTX Capital’s Portfolio SVRA Stock Details SVRA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-373,034	Closed	-$2.25M	–	960
2025 Q4	$2.25M	Buy	+373,034	New	+$1.83M	0.07%	291

Other funds holding SVRA

NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return

Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return

VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return

Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return

Polar Capital Holdings London, United Kingdom $42.4B AUM 181.11% 1-Year Est. Return

Vanguard Capital Management

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return

SummitTX Capital's SVRA Position: Q1 2026 in Review

SummitTX Capital sold out of Savara (SVRA) in Q1 2026, closing a stake of 373,034 shares — an estimated $2.25M sold.

SummitTX Capital first reported a position in SVRA in Q4 2025 and held it in 1 quarter. The position peaked at $2.25M in Q4 2025. 185 funds tracked by Wall St. Rank hold SVRA as of Q1 2026.

SummitTX Capital reported no remaining Savara position as of Q1 2026 after selling out during the quarter.
SummitTX Capital sold 373,034 Savara shares in Q1 2026, an estimated $2.25M.
SummitTX Capital first reported a position in Savara in Q4 2025 and held it in 1 quarter.
SummitTX Capital's Savara position peaked at $2.25M in Q4 2025.
185 funds tracked by Wall St. Rank held Savara as of Q1 2026.

Based on SummitTX Capital's 13F filing for Q1 2026, filed 15 May 2026.